72 related articles for article (PubMed ID: 21150776)
21. Phase I/II trial of vinorelbine and sorafenib in metastatic breast cancer.
Luu T; Frankel P; Chung C; Chow W; Mortimer J; Hurria A; Somlo G
Clin Breast Cancer; 2014 Apr; 14(2):94-100. PubMed ID: 24370210
[TBL] [Abstract][Full Text] [Related]
22. Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation.
Gebbia V; Mauceri G; Fallica G; Borsellino N; Tirrito ML; Testa A; Varvara F; Colombo A; Ferrera P
Oncology; 2002; 63(1):23-30. PubMed ID: 12187067
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
Rezai K; Urien S; Isambert N; Roche H; Dieras V; Berille J; Bonneterre J; Brain E; Lokiec F
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1529-36. PubMed ID: 21519841
[TBL] [Abstract][Full Text] [Related]
24. A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer.
Chan S; Campone M; Santoro A; Conte PF; Bostnavaron M; Nguyen L
Cancer Chemother Pharmacol; 2014 May; 73(5):903-10. PubMed ID: 24627219
[TBL] [Abstract][Full Text] [Related]
25. Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.
Ferrario C; Strepponi I; Esfahani K; Charamis H; Langleben A; Scarpi E; Nanni O; Miller WH; Panasci LC
PLoS One; 2016; 11(12):e0167906. PubMed ID: 27992451
[TBL] [Abstract][Full Text] [Related]
26. A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.
Kakolyris S; Kouroussis C; Koukourakis M; Mavroudis D; Malas K; Vardakis N; Bozionelou V; Kalbakis K; Georgoulias V
Oncology; 2002; 63(3):213-8. PubMed ID: 12381899
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer.
Blasinska-Morawiec M; Tubiana-Mathieu N; Fougeray R; Pinel MC; Bougnoux P
Breast; 2013 Feb; 22(1):58-63. PubMed ID: 23195794
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: a multicentric Turkish Oncology Group (TOG) trial.
Saip P; Eralp Y; Sen F; Karaca H; Ozkan M; Cetin B; Benekli M; Kucukoner M; Isikdogan A; Un O; Basaran G; Onur H
Breast; 2013 Oct; 22(5):628-33. PubMed ID: 23954396
[TBL] [Abstract][Full Text] [Related]
29. Vinorelbine combined with paclitaxel infused over 96 hours (VI-TA-96) for patients with metastatic breast carcinoma.
Cocconi G; Mambrini A; Quarta M; Vasini G; Bella MA; Ferrozzi F; Beretta MD
Cancer; 2000 Jun; 88(12):2731-8. PubMed ID: 10870055
[TBL] [Abstract][Full Text] [Related]
30. Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.
Antón A; Barnadas A; Florián J; Ribelles N; Lomas M; Lao J; González-Quintás A; Margelí M; Paules AB; Gayo J; Ramos M;
Clin Transl Oncol; 2011 Apr; 13(4):281-6. PubMed ID: 21493190
[TBL] [Abstract][Full Text] [Related]
31. A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinoma.
Pawlicki M; Rolski J; Zaluski J; Siedlecki P; Ramlau C; Tomzak P
Oncologist; 2002; 7(3):205-9. PubMed ID: 12065792
[TBL] [Abstract][Full Text] [Related]
32. Phase I study of concurrent vinorelbine and radiation therapy in high-risk postmastectomy breast cancer patients.
Honda K; Riku M; Iwase M; Hirasawa N; Yamada T; Goto Y; Kawada K
Breast Cancer; 2016 Sep; 23(5):701-5. PubMed ID: 26206720
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.
Baweja M; Suman VJ; Fitch TR; Mailliard JA; Bernath A; Rowland KM; Alberts SR; Kaur JS; Perez EA;
Ann Oncol; 2006 Apr; 17(4):623-9. PubMed ID: 16520332
[TBL] [Abstract][Full Text] [Related]
34. [A phase II study with mitoxantrone-vinorelbine association in the treatment of advanced breast cancer in elderly women].
Gladieff L; Houyau P; Mihura J; Martinez M; Caunes N; Chevreau C; Bugat R; Roché H
Bull Cancer; 1996 Sep; 83(9):703-6. PubMed ID: 8952644
[TBL] [Abstract][Full Text] [Related]
35. Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial.
Elomaa I; Joensuu H; Blomqvist C
Ann Oncol; 2003 May; 14(5):699-703. PubMed ID: 12702522
[TBL] [Abstract][Full Text] [Related]
36. [Updates on gemcitabine on metastatic breast cancer].
Gligorov J; Selle F; Khalil A; Abbas F; Namer M; Lotz JP
Bull Cancer; 2007; 94 Spec No Actualites():S90-4. PubMed ID: 17845977
[TBL] [Abstract][Full Text] [Related]
37. A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.
Twelves CJ; Dobbs NA; Curnow A; Coleman RE; Stewart AL; Tyrrell CJ; Canney P; Rubens RD
Br J Cancer; 1994 Nov; 70(5):990-3. PubMed ID: 7947109
[TBL] [Abstract][Full Text] [Related]
38. ZD0473 combined with other chemotherapeutic agents for the treatment of solid malignancies.
Douillard JY; Schiller J
Eur J Cancer; 2002 Dec; 38 Suppl 8():S25-31. PubMed ID: 12645909
[TBL] [Abstract][Full Text] [Related]
39. Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer.
Tortoriello A; Facchini G; Caponigro F; Santangelo M; Benassai G; Persico G; Citarella A; Carola M; Marzano N; Iaffaioli RV
Breast Cancer Res Treat; 1998 Jan; 47(1):91-7. PubMed ID: 9493980
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer.
Robles C; Furst AJ; Sriratana P; Lai S; Chua L; Donnelly E; Solomon J; Sundaram M; Feun L; Savaraj N
Oncol Rep; 2003; 10(4):885-9. PubMed ID: 12792740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
